12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Company News  |  Deals

Cellectis, Medicago deal

The companies partnered and will use Cellectis' nuclease technology to produce modified glycoproteins from tobacco leaves to develop...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >